X0508 4 2026-01-21 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001856371 Scanlan Sean F. C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 false true false false Chief Innovation Officer false Common Stock 2026-01-21 4 M false 53500 0.72 A 427099 D Common Stock 2026-01-22 4 A false 262500 0 A 689599 D Stock Option (Right to Buy) 0.72 2026-01-21 4 M false 53500 0 A 2020-01-26 2026-01-26 Common Stock 53500 0 D Includes 283,948 restricted stock units. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date. Includes 511,291 restricted stock units The stock option vested in equal annual installments over 4 years, commencing on January 26, 2016 with the last installment vesting on January 26, 2020. /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan 2026-01-23